Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets.

Vanderbilt investigators report the first use of a specialized type of MRI to study the hippocampus in patients with schizophrenia.

Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered.

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases.

Vanderbilt University investigators have identified a cellular receptor for a toxin from Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.

Nanibaa' Garrison, Ph.D., assistant professor of Pediatrics and Anthropology, has been appointed to serve on the Working Group on Diversity, which is an arm of the Advisory Committee to the Director (ACD) of the National Institutes of Health (NIH).

Last week in Langford Auditorium, Francis Collins, M.D., Ph.D., director of the National Institutes of Health (NIH), delivered what he referred to as a “romp through an awful lot of the landscape of biomedical research.”